Women receiving Ultra-Ostivone ^TM experienced a 29% decrease in NTx levels while those receiving the placebo experienced an increase.

The results of this study confirm the findings of other researchers that demonstrate the usefulness of ipriflavone at slowing the progression of bone loss in postmenopausal women.

Refer to the chart below for previous research study results on the ability of ipriflavone to prevent the decline in bone loss commonly seen after menopause.

Molecular structure of Ipriflavone

For additional information on ipriflavone, N-linked telopeptides and bone loss refer to the accompanying article entitled

Osteoporosis: A review focusing on ipriflavone and other key nutrients

Combine Ultra-Ostivone ^TM with our best calcium/ magnesium product Cal-Mag Chelate for maximum bone defense. Add any of our multivitamin formulas for the best in overall health maintenance and support.

For additional information on our complete line of bone health formulations including ipriflavone-containing products as well as calcium/magnesium formulations, such as Calcium Microcrystalline Hydroxyapatite,

refer to the latest Nutrition Dynamics, Inc. product catalog.

If you would like a copy of the complete study on Ultra-Ostivone, just let us know.

References
1) Halpner, A. D., Kellermann, G., Ahlgrimm, M. J. et al. The Effect of an Ipriflavone-Containing Supplement on Urinary N-Linked Telopeptide Levels in Postmenopausal Women. J Womens Health Gender Based Med In Press.

2) Gennari, C., Agnusdei, D., Crepaldi, G. et al. Effects of ipriflavone - a synthetic derivative of natural isoflavones - on bone mass loss in the early years after menopause. Menopause 1998;5:9-15.

3) Agnusdei, D., Crepaldi, G., Isaia, G., et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 1997;61:142-147.

4) Gennari, C., Adami, S., Agnusdei, D. et al. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcif Tissue Int 1997;61:S19-S22.

Ostivone® is a trademark of Technical Sourcing International